Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Cayman Chemical Oxymetazoline (hydrochloride), Purity: ≥95%, CAS: 2315-02-8, 1 g
SDP

Catalog No. 502995149
Encompass_Preferred

An agonist of α1- and α2-ARs (Kds = 6, 320, and 390 nM for α1A-, α1B-, and α1D-ARs, respectively, Ki = 15 nM for α2-AR); acts as an agonist of 5-HT1 receptors (Kds = 4.68, 25.7, 5.01 nM for 5-HT1A, 5-HT1B, and 5-HT1D, respectively); increases intracellular calcium levels in CHO cells transfected with the α1A-AR (EC50 = 40.7 nM); acts as a partial agonist of the α2-AR in perfused rat heart (IC50 = 63 nM and EC50 = 13.5 nM for norepinephrine release); acts as an agonist and antagonist of the 5-HT1C receptor in the presence of methiothepin and clonidine, respectively (Kds = 110 and 257 nM, respectively); inhibits forskolin-stimulated adenylate cyclase activity (EC50s = 18.6, 24.0, and 44.7 nM in tissues expressing high levels of 5-HT1A, 5-HT1B, and 5-HT1D receptors, respectively) and accumulation of inositol phosphates (EC50 = 269 nM in pig choroid plexus preparations, which highly express 5-HT1C receptors); decreases nasal pressure in dogs by 6.9% when used at a dose of 0.2 μg/kg

Catalog No. 50-299-5149 Supplier Cayman Chemical Supplier No. 238261 G
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

An agonist of α1- and α2-ARs (Kds = 6, 320, and 390 nM for α1A-, α1B-, and α1D-ARs, respectively, Ki = 15 nM for α2-AR); acts as an agonist of 5-HT1 receptors (Kds = 4.68, 25.7, 5.01 nM for 5-HT1A, 5-HT1B, and 5-HT1D, respectively); increases intracellular calcium levels in CHO cells transfected with the α1A-AR (EC50 = 40.7 nM); acts as a partial agonist of the α2-AR in perfused rat heart (IC50 = 63 nM and EC50 = 13.5 nM for norepinephrine release); acts as an agonist and antagonist of the 5-HT1C receptor in the presence of methiothepin and clonidine, respectively (Kds = 110 and 257 nM, respectively); inhibits forskolin-stimulated adenylate cyclase activity (EC50s = 18.6, 24.0, and 44.7 nM in tissues expressing high levels of 5-HT1A, 5-HT1B, and 5-HT1D receptors, respectively) and accumulation of inositol phosphates (EC50 = 269 nM in pig choroid plexus preparations, which highly express 5-HT1C receptors); decreases nasal pressure in dogs by 6.9% when used at a dose of 0.2 μg/kg

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.